Abstract
The main objective of this study was to evaluate the safety and efficacy profile of intralesional triamcinolone acetonide (TA) injection for the treatment of primary chalazion. We study included 20 patients in our study who had chalazion persis ting for nearly one month. All of them did not respond to applied topical antimicrobial therapy. These patients were taking intralesional triamcinolone injection as a mode of treatment of chalazion (dosage of 2 – 4 mg). Patients were being evaluated 1 day, 14 days and 1 month after intralesional triamcinolone injection. We noted that treating chalazion with intralesional triamcinolone injection was much more convenient for patients, less time consuming to treat and did not require extra topical antimicrobial treatment. Keywords: Chalazion, Triamcinolone injection, Efficacy of therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Clinical and Experimental Ophthalmology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
